These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30681495)

  • 1. Innovative analysis of predictors for overall survival from systemic non-Hodgkin T cell lymphoma using quantile regression analysis.
    Huang DY; Hu YF; Wei N; Fu L; Wu L; Shen J; Wang JS; Wang Z
    Chin Med J (Engl); 2019 Feb; 132(3):294-301. PubMed ID: 30681495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
    Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
    [No Abstract]   [Full Text] [Related]  

  • 3. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
    Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and prognostic factors of primary gastric lymphoma: A retrospective study with 165 cases.
    Wang YG; Zhao LY; Liu CQ; Pan SC; Chen XL; Liu K; Zhang WH; Yang K; Chen XZ; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
    Medicine (Baltimore); 2016 Aug; 95(31):e4250. PubMed ID: 27495029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the immunophenotype versus the International Prognostic Index in aggressive non-Hodgkin's lymphoma.
    Intragumtornchai T; Rotnakkarin P; Sutcharitchan P; Wannagrairoj P
    Clin Lymphoma; 2003 Jun; 4(1):52-5. PubMed ID: 12837156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retrospective analysis of the clinical features and prognostic factors of 370 patients with advanced-stage diffuse large B-cell lymphoma].
    Han Y; Qin Y; He XH; Yang JL; Liu P; Zhang CG; Zhou LQ; Zhou SY; Gui L; Song YW; Sun Y; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):456-461. PubMed ID: 29936773
    [No Abstract]   [Full Text] [Related]  

  • 7. Anatomic distribution, clinical features, and survival data of 87 cases primary gastrointestinal lymphoma.
    Ge Z; Liu Z; Hu X
    World J Surg Oncol; 2016 Mar; 14():85. PubMed ID: 26988370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell non-Hodgkin's lymphoma in adults: clinicopathological characteristics, response to treatment and prognostic factors.
    Reiser M; Josting A; Soltani M; Staib P; Salzberger B; Diehl V; Engert A
    Leuk Lymphoma; 2002 Apr; 43(4):805-11. PubMed ID: 12153168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognosis of primary non-Hodgkin's lymphoma of the breast].
    Guo HY; Zhao XM; Cao JN; Hu XC; Yin JL; Hong XN; Li J
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):200-2. PubMed ID: 18756936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma.
    Niu JY; Tian T; Zhu HY; Liang JH; Wu W; Cao L; Lu RN; Wang L; Li JY; Xu W
    Ann Hematol; 2018 Oct; 97(10):1841-1849. PubMed ID: 29860562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis analysis of primary breast diffuse large B cell lymphoma].
    Zhu YH; Meng WJ; He LH; Jia YS; Tong ZS
    Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):235-240. PubMed ID: 30917462
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic significance of serum beta-2 microglobulin in patients with non-Hodgkin lymphoma.
    Wu L; Wang T; Gui W; Lin H; Xie K; Wang H; Gao T; Zhang X; Liu L; Han T; Tian Y; Hou L
    Oncology; 2014; 87(1):40-7. PubMed ID: 24969158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma.
    Kato A; Imai Y; Aoki K; Tabata S; Matsushita A; Hashimoto H; Takahashi T; Ishikawa T
    Ann Hematol; 2014 Jul; 93(7):1185-91. PubMed ID: 24526138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncutaneous T-cell lymphomas. Recognition of a lymphoma type (large cell anaplastic) with a relatively favorable prognosis.
    de Bruin PC; Noorduyn AL; van der Valk P; van Heerde P; van Diest PJ; van de Sandt MM; Ossenkoppele GJ; Meijer CJ
    Cancer; 1993 Apr; 71(8):2604-12. PubMed ID: 8453584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphoma.
    Micallef IN; Remstein ED; Ansell SM; Colgan JP; Inwards DJ; Johnston PB; Lewis JT; Markovic SN; Porrata LF; White WL; Witzig TE; Ristow K; Habermann TM
    Leuk Lymphoma; 2006 Sep; 47(9):1794-9. PubMed ID: 17064990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological study on peripheral T-cell non-Hodgkin lymphoma with bone marrow involvement: a retrospective analysis from China.
    Tong H; Ren Y; Qian W; Xiao F; Mai W; Meng H; Jin J
    Int J Hematol; 2009 Oct; 90(3):303-310. PubMed ID: 19728028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma.
    Laudi N; Arora M; Burns LJ; Miller JS; McGlave PB; Barker JN; Ramsay NK; Orchard PJ; Macmillan ML; Weisdorf DJ
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):129-35. PubMed ID: 15682074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized primary non-Hodgkin lymphoma of the breast.
    Ha CS; Dubey P; Goyal LK; Hess M; Cabanillas F; Cox JD
    Am J Clin Oncol; 1998 Aug; 21(4):376-80. PubMed ID: 9708637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical features and treatment outcome of patients with non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis].
    Sun SR; Wu M; Wulipan F; Shen L; Ma JX; Chen PP; Hu YW; Zhang HD; Xie YH
    Zhonghua Xue Ye Xue Za Zhi; 2021 Apr; 42(4):324-331. PubMed ID: 33979978
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the proliferative index as a prognostic factor in diffuse large cell lymphoma: correlation with the International Index.
    Ansell SM; Kurtin PJ; Stenson M; Habermann TM; Greipp PR; Therneau TM; Witzig TE
    Leuk Lymphoma; 1999 Aug; 34(5-6):529-37. PubMed ID: 10492076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.